Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Evaluating Gut Microbiota Modification as a Next-Generation Therapy for Obesity and Diabetes

Author(s): Md. Imran Hossain, Sajidur Rahman Akash*, Md. Omor Faruk, Sanjida Islam Mimi, Imtiaj Hossain Chowdhury, Md Shariful Islam, Md. Mahbubol Alam and Md. Sarafat Ali*

Volume 20, Issue 3, 2024

Published on: 07 July, 2023

Article ID: e150523216913 Pages: 11

DOI: 10.2174/1573399820666230515115307

Price: $65

Abstract

The human body is a complex ecosystem that thrives on symbiosis. It is estimated that around 10^14 commensal microorganisms inhabit the human body, with the gut microbiota being one of the most diverse and complex populations of bacteria. This community is thought to comprise over a thousand different species that play a crucial role in the development of critical human diseases such as cancer, obesity, diabetes, mental depression, hypertension, and others. The gut microbiota has been identified as one of the most recent contributors to these metabolic disorders. With the emergence of inexpensive and high-performance sequence technology, our understanding of the function of the intestinal microbiome in host metabolism regulation and the development of (cardio) metabolic diseases has increased significantly. The symbiotic relationship between the gut microbiota and the host is essential for properly developing the human metabolic system. However, if this balance is disrupted by various factors such as infection, diet, exercise, sleep patterns, or exposure to antibiotics, it can lead to the development of various diseases in the body, including obesity and diabetes type 1 and 2. While many approaches and medications have been developed globally to treat these diseases, none have proven to be entirely effective, and many show side effects. Therefore, scientists believe that treating the gut microbiota using tried-and-true methods is the best option for combating obesity and diabetes. In this study, we aim to identify several feasible ways and prospects for gut microbiota therapy that can shape a new format for the treatment of obesity and diabetes.

[1]
Santacruz A, Marcos A, Wärnberg J, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009; 17(10): 1906-15.
[http://dx.doi.org/10.1038/oby.2009.112] [PMID: 19390523]
[2]
Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18(1): 190-5.
[http://dx.doi.org/10.1038/oby.2009.167] [PMID: 19498350]
[3]
Vich Vila A, Collij V, Sanna S, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 2020; 11(1): 362.
[http://dx.doi.org/10.1038/s41467-019-14177-z] [PMID: 31953381]
[4]
Monk AB, Rees CD, Barrow P, Hagens S, Harper DR. Bacteriophage applications: Where are we now? Lett Appl Microbiol 2010; 51(4): 363-9.
[http://dx.doi.org/10.1111/j.1472-765X.2010.02916.x] [PMID: 20796209]
[5]
Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage 2011; 1(2): 66-85.
[http://dx.doi.org/10.4161/bact.1.2.15845] [PMID: 22334863]
[6]
Campbell AP, Merrett MN, Kettlewell M, Mortensen NJ, Jewell DP. Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: Their association with inflammatory change and faecal stasis. J Clin Pathol 1994; 47(9): 834-8.
[http://dx.doi.org/10.1136/jcp.47.9.834] [PMID: 7962653]
[7]
Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013; 5(178): 178ra41.
[http://dx.doi.org/10.1126/scitranslmed.3005687] [PMID: 23536013]
[8]
Daliri EBM, Lee BH. New perspectives on probiotics in health and disease. Food Sci Hum Wellness 2015; 4(2): 56-65.
[http://dx.doi.org/10.1016/j.fshw.2015.06.002]
[9]
Levin BR, Bull JJ. Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2004; 2(2): 166-73.
[http://dx.doi.org/10.1038/nrmicro822] [PMID: 15040264]
[10]
Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5(7): e177.
[http://dx.doi.org/10.1371/journal.pbio.0050177] [PMID: 17594176]
[11]
Zhang C, Zhang M, Wang S, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010; 4(2): 232-41.
[http://dx.doi.org/10.1038/ismej.2009.112] [PMID: 19865183]
[12]
Karlsson CLJ, Önnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 2012; 20(11): 2257-61.
[http://dx.doi.org/10.1038/oby.2012.110] [PMID: 22546742]
[13]
Moran CP, Shanahan F. Gut microbiota and obesity: Role in aetiology and potential therapeutic target. Best Pract Res Clin Gastroenterol 2014; 28(4): 585-97.
[http://dx.doi.org/10.1016/j.bpg.2014.07.005] [PMID: 25194177]
[14]
Graf D, Di Cagno R, Fåk F, et al. Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis 2015; 26(1): 26164.
[PMID: 25656825]
[15]
Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 2011; 108 (Suppl. 1): 4554-61.
[http://dx.doi.org/10.1073/pnas.1000087107] [PMID: 20847294]
[16]
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308(5728): 1635-8.
[http://dx.doi.org/10.1126/science.1110591] [PMID: 15831718]
[17]
Erken M, Lutz C, McDougald D. The rise of pathogens: Predation as a factor driving the evolution of human pathogens in the environment. Microb Ecol 2013; 65(4): 860-8.
[http://dx.doi.org/10.1007/s00248-013-0189-0] [PMID: 23354181]
[18]
Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498(7452): 99-103.
[http://dx.doi.org/10.1038/nature12198] [PMID: 23719380]
[19]
Gilli G, Scursatone E, Bono R, Natale P, Grosa M. An overview of atmospheric pollution in Italy before the use of new gasoline. Sci Total Environ 1990; 93: 51-6.
[http://dx.doi.org/10.1016/0048-9697(90)90093-A] [PMID: 2360030]
[20]
Gauffin Cano P, Santacruz A, Moya Á, Sanz Y. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One 2012; 7(7): e41079.
[http://dx.doi.org/10.1371/journal.pone.0041079] [PMID: 22844426]
[21]
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334(6052): 105-8.
[http://dx.doi.org/10.1126/science.1208344]
[22]
Hu GX, Chen GR, Xu H, Ge RS, Lin J. Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome. Med Hypotheses 2010; 74(1): 123-6.
[http://dx.doi.org/10.1016/j.mehy.2009.07.022] [PMID: 19665312]
[23]
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23(4): 427-36.
[http://dx.doi.org/10.1007/s11695-012-0864-0] [PMID: 23338049]
[24]
Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012; 9(10): 577-89.
[http://dx.doi.org/10.1038/nrgastro.2012.156] [PMID: 22945443]
[25]
Parracho HMRT, Burrowes BH, Enright MC, McConville ML, Harper DR. The role of regulated clinical trials in the development of bacteriophage therapeutics. J Mol Genet Med 2012; 6(1): 279-86.
[http://dx.doi.org/10.4172/1747-0862.1000050] [PMID: 22872803]
[26]
Nadal I, Santacruz A, Marcos A, et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes 2009; 33(7): 758-67.
[http://dx.doi.org/10.1038/ijo.2008.260] [PMID: 19050675]
[27]
Pérez J, Moraleda-Muñoz A, Marcos-Torres FJ, Muñoz-Dorado J. Bacterial predation: 75 years and counting! Environ Microbiol 2016; 18(3): 766-79.
[http://dx.doi.org/10.1111/1462-2920.13171]
[28]
Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464(7285): 59-65.
[http://dx.doi.org/10.1038/nature08821] [PMID: 20203603]
[29]
Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299(5615): 2074-6.
[http://dx.doi.org/10.1126/science.1080029]
[30]
Gill J, Hyman P. Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 2010; 11(1): 2-14.
[http://dx.doi.org/10.2174/138920110790725311] [PMID: 20214604]
[31]
Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005; 307(5717): 1955-9.
[http://dx.doi.org/10.1126/science.1109051]
[32]
Natividad JMM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications. Pharmacol Res 2013; 69(1): 42-51.
[http://dx.doi.org/10.1016/j.phrs.2012.10.007] [PMID: 23089410]
[33]
Kaoutari AE, Armougom F, Gordon JI, Raoult D, Henrissat B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol 2013; 11(7): 497-504.
[http://dx.doi.org/10.1038/nrmicro3050] [PMID: 23748339]
[34]
Kong LC, Holmes BA, Cotillard A, et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS One 2014; 9(10): e109434.
[http://dx.doi.org/10.1371/journal.pone.0109434] [PMID: 25330000]
[35]
Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489(7415): 242-9.
[http://dx.doi.org/10.1038/nature11552] [PMID: 22972297]
[36]
Roesch LFW, Lorca GL, Casella G, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 2009; 3(5): 536-48.
[http://dx.doi.org/10.1038/ismej.2009.5] [PMID: 19225551]
[37]
Li XW, Chen HP, He YY, et al. Effects of rich-polyphenols extract of dendrobium loddigesii on anti-diabetic, anti-inflammatory, anti-oxidant, and gut microbiota modulation in db/db Mice. Molecules 2018; 23(12): 3245.
[http://dx.doi.org/10.3390/molecules23123245] [PMID: 30544624]
[38]
Brahe LK, Le Chatelier E, Prifti E, et al. Dietary modulation of the gut microbiota – a randomised controlled trial in obese postmenopausal women. Br J Nutr 2015; 114(3): 406-17.
[http://dx.doi.org/10.1017/S0007114515001786] [PMID: 26134388]
[39]
Dicks L, Botes M. Probiotic lactic acid bacteria in the gastro-intestinal tract: Health benefits, safety and mode of action. Benef Microbes 2010; 1(1): 11-29.
[http://dx.doi.org/10.3920/BM2009.0012] [PMID: 21831747]
[40]
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489(7415): 220-30.
[http://dx.doi.org/10.1038/nature11550] [PMID: 22972295]
[41]
Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291(5505): 881-4.
[http://dx.doi.org/10.1126/science.291.5505.881]
[42]
Li M, Liang P, Li Z, et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front Microbiol 2015; 6(7): 692.
[http://dx.doi.org/10.3389/fmicb.2015.00692] [PMID: 26217323]
[43]
Wu M, McNulty NP, Rodionov DA, Khoroshkin MS, Griffin NW, Cheng J. Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides. Science 2015; 330(6256): aac5992.
[http://dx.doi.org/10.1126/science.aac5992]
[44]
Martín R, Miquel S, Benevides L, et al. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. prausnitzii as a next-generation probiotic. Front Microbiol 2017; 8(6): 1226.
[http://dx.doi.org/10.3389/fmicb.2017.01226] [PMID: 28713353]
[45]
Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010; 7(9): 503-14.
[http://dx.doi.org/10.1038/nrgastro.2010.117] [PMID: 20664519]
[46]
Morello E, Saussereau E, Maura D, Huerre M, Touqui L, Debarbieux L. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: First steps towards treatment and prevention. PLoS One 2011; 6(2): e16963.
[http://dx.doi.org/10.1371/journal.pone.0016963] [PMID: 21347240]
[47]
de Wit N, Derrien M, Bosch-Vermeulen H, et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol 2012; 303(5): G589-99.
[http://dx.doi.org/10.1152/ajpgi.00488.2011] [PMID: 22700822]
[48]
Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2015; 2(1): ofv004.
[http://dx.doi.org/10.1093/ofid/ofv004] [PMID: 26034755]
[49]
Kubota N, Terauchi Y, Kubota T, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 2006; 281(13): 8748-55.
[http://dx.doi.org/10.1074/jbc.M505649200] [PMID: 16431926]
[50]
Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5(2): e9085.
[http://dx.doi.org/10.1371/journal.pone.0009085] [PMID: 20140211]
[51]
Jakobsen M. Predatory prokaryotes: An emerging research opportunity. J Mol Microbiol Biotechnol 2002; 4(5): 467-77.
[52]
Jurkevitch E, Davidov Y. Predatory Prokaryotes, Biology, Ecology and Evolution Microbiol Monogr. Springer 2007; p. 4.
[53]
Lee NK, Kim HW, Chang HI, et al. Probiotic properties of Lactobacillus plantarum NK181 isolated from Jeotgal, a Korean fermented food. Food Sci Biotechnol 2006; 15(2): 227-31.
[54]
Yang Q, Lin SL, Kwok MK, Leung GM, Schooling CM. The roles of 27 genera of human gut microbiota in ischemic heart disease, type 2 diabetes mellitus, and their risk factors: A mendelian randomization study. Am J Epidemiol 2018; 187(9): 1916-22.
[http://dx.doi.org/10.1093/aje/kwy096] [PMID: 29800124]
[55]
Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490(7418): 55-60.
[http://dx.doi.org/10.1038/nature11450] [PMID: 23023125]
[56]
Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011; 94(1): 58-65.
[http://dx.doi.org/10.3945/ajcn.110.010132] [PMID: 21543530]
[57]
Berg R. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4(11): 430-5.
[http://dx.doi.org/10.1016/0966-842X(96)10057-3] [PMID: 8950812]
[58]
Clarke SF, Murphy EF, O’Sullivan O, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 2014; 63(12): 1913-20.
[http://dx.doi.org/10.1136/gutjnl-2013-306541] [PMID: 25021423]
[59]
Claus SP. Development of personalized functional foods needs metabolic profiling. Curr Opin Clin Nutr Metab Care 2014; 17(6): 567-73.
[http://dx.doi.org/10.1097/MCO.0000000000000107] [PMID: 25137506]
[60]
Tian J, Dang HN, Yong J, et al. Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS One 2011; 6(9): e25338.
[http://dx.doi.org/10.1371/journal.pone.0025338] [PMID: 21966503]
[61]
Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143(4): 913-6.
[http://dx.doi.org/10.1053/j.gastro.2012.06.031] [PMID: 22728514]
[62]
Ussar S, Griffin NW, Bezy O, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab 2015; 22(3): 516-30.
[http://dx.doi.org/10.1016/j.cmet.2015.07.007] [PMID: 26299453]
[63]
Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab 2015; 22(2): 228-38.
[http://dx.doi.org/10.1016/j.cmet.2015.07.009] [PMID: 26244932]
[64]
Voreades N, Kozil A, Weir TL. Diet and the development of the human intestinal microbiome. Front Microbiol 2014; 5(9): 494.
[http://dx.doi.org/10.3389/fmicb.2014.00494] [PMID: 25295033]
[65]
Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38: 1-12.
[http://dx.doi.org/10.1016/j.bbi.2013.12.015] [PMID: 24370461]
[66]
Yassour M, Lim MY, Yun HS, Tickle TL, Sung J, Song Y-M, et al. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med 2016; 8(1): 1-14.
[http://dx.doi.org/10.1186/s13073-016-0271-6]
[67]
Gao Z, Yin J, Zhang J, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58(7): 1509-17.
[http://dx.doi.org/10.2337/db08-1637] [PMID: 19366864]
[68]
Akash S, Hossain M, Ali M. Devising a multi epitope vaccine toward the dengue virus using the computational method in Bangladesh. J Adv Biotechnol Exp Ther 2023; 6(1): 44.
[http://dx.doi.org/10.5455/jabet.2023.d105]
[69]
Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci 2009; 106(7): 2365-70.
[http://dx.doi.org/10.1073/pnas.0812600106] [PMID: 19164560]
[70]
Zhang X, Fang Z, Zhang C, et al. Effects of acarbose on the gut microbiota of prediabetic patients: A Randomized, double-blind, controlled crossover trial. Diabetes Ther 2017; 8(2): 293-307.
[http://dx.doi.org/10.1007/s13300-017-0226-y] [PMID: 28130771]
[71]
Laursen MF, Andersen LBB, Michaelsen KF, et al. Infant gut microbiota development is driven by transition to family foods independent of maternal obesity. MSphere 2016; 1(1): e00069-15.
[http://dx.doi.org/10.1128/mSphere.00069-15] [PMID: 27303699]
[72]
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444(7122): 1027-31.
[73]
Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4(9): e7125.
[http://dx.doi.org/10.1371/journal.pone.0007125] [PMID: 19774074]
[74]
Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008; 88(4): 894-9.
[http://dx.doi.org/10.1093/ajcn/88.4.894] [PMID: 18842773]
[75]
Kalliomäki M, Carmen Collado M, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87(3): 534-8.
[http://dx.doi.org/10.1093/ajcn/87.3.534] [PMID: 18326589]
[76]
Balamurugan R, George G, Kabeerdoss J, Hepsiba J, Chandragunasekaran AMS, Ramakrishna BS. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br J Nutr 2010; 103(3): 335-8.
[http://dx.doi.org/10.1017/S0007114509992182] [PMID: 19849869]
[77]
Payne AN, Chassard C, Zimmermann M, Müller P, Stinca S, Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes 2011; 1(7): e12.
[http://dx.doi.org/10.1038/nutd.2011.8] [PMID: 23154580]
[78]
Patil DP, Dhotre DP, Chavan SG, et al. Molecular analysis of gut microbiota in obesity among Indian individuals. J Biosci 2012; 37(4): 647-57.
[http://dx.doi.org/10.1007/s12038-012-9244-0] [PMID: 22922190]
[79]
Xu P, Li M, Zhang J, Zhang T. Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol 2012; 12(1): 283.
[http://dx.doi.org/10.1186/1471-2180-12-283] [PMID: 23190705]
[80]
Simões CD, Maukonen J, Kaprio J, Rissanen A, Pietiläinen KH, Saarela M. Habitual dietary intake is associated with stool microbiota composition in monozygotic twins. J Nutr 2013; 143(4): 417-23.
[http://dx.doi.org/10.3945/jn.112.166322] [PMID: 23343669]
[81]
Ferrer M, Ruiz A, Lanza F, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ Microbiol 2013; 15(1): 211-26.
[http://dx.doi.org/10.1111/j.1462-2920.2012.02845.x] [PMID: 22891823]
[82]
Bervoets L, Van Hoorenbeeck K, Kortleven I, et al. Differences in gut microbiota composition between obese and lean children: A cross-sectional study. Gut Pathog 2013; 5(1): 10.
[http://dx.doi.org/10.1186/1757-4749-5-10] [PMID: 23631345]
[83]
Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57(6): 1470-81.
[http://dx.doi.org/10.2337/db07-1403] [PMID: 18305141]
[84]
Kumar MV, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328(5975): 228-31.
[85]
Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27(2): 104-19.
[http://dx.doi.org/10.1111/j.1365-2036.2007.03562.x] [PMID: 17973645]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy